Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures.
暂无分享,去创建一个
Andrew N Hoofnagle | A. Hoofnagle | T. Vaisar | Jessica O Becker | Tomas Vaisar | Giorgio Cavigiolio | M. Oda | Giorgio Cavigiolio | Michael N Oda | Philip Mayer | Jessica O. Becker | Philip S. Mayer
[1] Robert L Wilensky,et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.
[2] Christoph H Borchers,et al. A Human Proteome Detection and Quantitation Project* , 2009, Molecular & Cellular Proteomics.
[3] S. Gygi,et al. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Mann,et al. Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.
[5] Christoph H Borchers,et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.
[6] Subramaniam Pennathur,et al. Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome , 2008, Circulation.
[7] Amanda G. Paulovich,et al. An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers* , 2009, Molecular & Cellular Proteomics.
[8] Andrew N Hoofnagle,et al. Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins , 2009, Journal of Lipid Research.
[9] R. Kaaks,et al. Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: comparison with ELISA. , 2009, Journal of immunological methods.
[10] F. Vandenesch,et al. Isotope-labeled Protein Standards , 2007, Molecular & Cellular Proteomics.
[11] Andrew N Hoofnagle,et al. Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry. , 2010, Clinical chemistry.
[12] Nichole L. King,et al. Human Plasma PeptideAtlas , 2005, Proteomics.
[13] Leigh Anderson,et al. Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins* , 2006, Molecular & Cellular Proteomics.
[14] S. Kahn,et al. Effects of Insulin Resistance and Obesity on Lipoproteins and Sensitivity to Egg Feeding , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[15] D. Chelius,et al. Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. , 2002, Analytical chemistry.
[16] Lukas N. Mueller,et al. Full Dynamic Range Proteome Analysis of S. cerevisiae by Targeted Proteomics , 2009, Cell.
[17] Andrew N Hoofnagle,et al. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. , 2009, Journal of immunological methods.
[18] C. Seger,et al. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. , 2010, Clinical chemistry.
[19] Subramaniam Pennathur,et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.
[20] Andrew N Hoofnagle,et al. Quantitative clinical proteomics by liquid chromatography-tandem mass spectrometry: assessing the platform. , 2010, Clinical chemistry.